Liquidia Corporation $LQDA Stock: Profund Advisors LLC Increases Stake

Profund Advisors LLC lifted its holdings in shares of Liquidia Corporation (NASDAQ:LQDA) by 226.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,572 shares of the company’s stock after acquiring an additional 17,736 shares during the quarter. Profund Advisors LLC’s holdings in Liquidia were worth $774,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Pinnacle Wealth Planning Services Inc. grew its stake in shares of Liquidia by 26.2% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the period. Globeflex Capital L P bought a new position in Liquidia in the 2nd quarter worth approximately $175,000. Nykredit A S purchased a new position in Liquidia in the 2nd quarter valued at approximately $177,000. Sterling Capital Management LLC raised its holdings in Liquidia by 839.1% during the 3rd quarter. Sterling Capital Management LLC now owns 2,329 shares of the company’s stock valued at $70,000 after acquiring an additional 2,081 shares during the period. Finally, Nisa Investment Advisors LLC raised its holdings in Liquidia by 13.8% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company’s stock valued at $80,000 after acquiring an additional 320 shares during the period. Institutional investors own 64.54% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on LQDA. BTIG Research raised Liquidia from a “neutral” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Wednesday, October 14th. Wedbush set a $58.00 price objective on shares of Liquidia in a research note on Friday, October 2nd. Piper Sandler set a $129.00 price target on shares of Liquidia in a report on Friday, July 24th. Citigroup reissued a “neutral” rating on shares of Liquidia in a research note on Thursday, October 1st. Finally, HC Wainwright lifted their price target on Liquidia from $58.00 to $65.00 and gave the company a “buy” rating in a research report on Thursday, October 15th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Liquidia currently has a consensus rating of “Hold” and an average target price of $72.85.

Liquidia Stock Up 12.3%

LQDA opened at $47.38 on Thursday. The company has a market capitalization of $4.24 billion, a PE ratio of 30.80, a PEG ratio of 0.37 and a beta of 0.40. The company has a current ratio of 2.31, a quick ratio of 2.12 and a debt-to-equity ratio of 0.63. The firm’s 50 day simple moving average is $51.43 and its two-hundred day simple moving average is $54.38. Liquidia Corporation has a 1-year low of $22.31 and a 1-year high of $93.61.

Liquidia (NASDAQ:LQDA) last issued its earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The business had revenue of $171.68 million for the quarter, compared to the consensus estimate of $168.48 million. During the same period last year, the business posted ($0.49) EPS. The firm’s revenue for the quarter was up 1842.1% compared to the same quarter last year. As a group, equities analysts forecast that Liquidia Corporation will post 2.05 EPS for the current year.

Insider Transactions at Liquidia

In related news, Director Stephen Bloch sold 235,477 shares of the company’s stock in a transaction on Monday, October 5th. The shares were sold at an average price of $27.13, for a total transaction of $6,388,491.01. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Rajeev Saggar sold 50,000 shares of the firm’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $74.06, for a total transaction of $3,703,000.00. Following the transaction, the insider directly owned 142,265 shares of the company’s stock, valued at $10,536,145.90. The trade was a 26.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 566,579 shares of company stock valued at $25,746,120. 25.60% of the stock is owned by corporate insiders.

About Liquidia

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.